2017
DOI: 10.1167/iovs.17-22680
|View full text |Cite
|
Sign up to set email alerts
|

Corneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1

Abstract: PurposeTo evaluate the angiogenic properties of corneal derived mesenchymal stromal cells (Co-MSC).MethodsCo-MSCs were extracted from human cadaver, and wild-type (C57BL/6J) and SERPINF1−/− mice corneas. The MSC secretome was collected in a serum-free medium. Human umbilical vein endothelial cell (HUVEC) tube formation and fibrin gel bead assay (FIBA) sprout formation were used to assess the angiogenic properties of Co-MSC secretome. Complete corneal epithelial debridement was used to induce corneal neovascula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
52
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 52 publications
(54 citation statements)
references
References 72 publications
(80 reference statements)
0
52
0
2
Order By: Relevance
“…MSCs are found in most adult tissues, including cornea/limbus, 7 and play an important role in tissue repair and maintenance. 1 Over the past decade, they have been increasingly investigated for their therapeutic potential in a wide range of human diseases given their anti-inflammatory and regenerative properties.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…MSCs are found in most adult tissues, including cornea/limbus, 7 and play an important role in tissue repair and maintenance. 1 Over the past decade, they have been increasingly investigated for their therapeutic potential in a wide range of human diseases given their anti-inflammatory and regenerative properties.…”
mentioning
confidence: 99%
“…It is now widely accepted that the therapeutic effects of MSCs are mediated largely through their secreted factors. 7 11 We previously showed that human corneal MSC (cMSC) secretome is able to inhibit corneal neovascularization, 7 and modulate macrophages toward an anti-angiogenic and anti-inflammatory immunophenotype, 12 suggesting that human cMSC secreted factors may be used therapeutically in ocular surface diseases. Secreted factors present considerable advantages over cells regarding manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product.…”
mentioning
confidence: 99%
“…The therapeutic potential of cMSCs has been demonstrated in both in vitro and in vivo laboratory studies, 19,30 and cMSCs could provide a novel source of MSCs for corneal regenerative treatments. For clinical applications, however, protocols for cMSC isolation and expansion will have to be scalable while maintaining high reproducibility.…”
Section: Discussionmentioning
confidence: 99%
“…These antiangiogenic properties were found to be conferred in part by the secretion of pigment epithelium-derived factor and soluble fms-like tyrosine kinase-1 and low secretion of vascular endothelial growth factor A. 19 cMSCs also induce secretion of antiinflammatory factors by the macrophages and modulate their phenotype to an inflammation-resolving phenotype, 30 in addition to inhibiting T-cell proliferation. 42 Other studies have shown that cMSCs can induce increased cytokeratin 12-positive corneal epithelial cells and decreased neovascularization, conjunctivalization, and K8-positive conjunctival goblet cells.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation